Alterations in vestibular sensory processing following G-transitions lead to motion sickness and spatial disorientation upon return to Earth’s gravity. The use of non-pharmaceutical mitigation for motion sickness has several potential advantages over drug treatment options. The purpose of this study was to validate a non-pharmaceutical tool using galvanic vestibular reduction (GVR) to mitigate G-transitional induced motion sickness and spatial disorientation.
Preliminary Results Using Galvanic Vestibular Reduction as a Non-Pharmaceutical Tool for Motion Sickness Mitigation
2022 Human Research Program Investigators’ Workshop (HRP IWS 2022) ; 2022 ; Virtual, US
Aufsatz (Konferenz)
Keine Angabe
Englisch
GVS Method and apparatus for motion sickness abatement using Galvanic Vestibular Stimulation
Europäisches Patentamt | 2019
|The vestibular system and motion sickness
British Library Conference Proceedings | 1999
|